Ascent Group LLC Buys New Position in SPDR S&P Biotech ETF $XBI

Ascent Group LLC bought a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 3,883 shares of the exchange traded fund’s stock, valued at approximately $473,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Capital A Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech ETF during the second quarter worth approximately $26,000. Davis Capital Management purchased a new position in shares of SPDR S&P Biotech ETF during the third quarter worth approximately $35,000. Halbert Hargrove Global Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF during the third quarter worth approximately $40,000. Barnes Dennig Private Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth approximately $48,000. Finally, Premier Financial Group purchased a new position in shares of SPDR S&P Biotech ETF during the third quarter worth approximately $50,000.

SPDR S&P Biotech ETF Stock Performance

XBI stock opened at $130.65 on Thursday. The company has a market capitalization of $7.96 billion, a PE ratio of 11.47 and a beta of 0.91. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $133.27. The company’s 50 day moving average price is $125.11 and its two-hundred day moving average price is $119.10.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.